Atlas Trials

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

Clinical trial NCT05633927 · COMPLETED

Trial details

NCT number
NCT05633927
Sponsor
Hospitales Universitarios Virgen del Rocío
Status
COMPLETED
Study type
OBSERVATIONAL
SARS-CoV-2 RNA VaccinesHIV Infection
Start date
2021-04-01
Primary completion
2022-03-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.